Mayne Pharma 被Wilsons從增持下調至市場權重 >MYX.AU
道瓊斯02/26 16:54 (美東)
Canaccord Genuity將Mayne Pharma的目標價下調6.6%至A$6.25/股
道瓊斯2024/08/26 00:24 (美東)